# Efficacy and Safety of Different Dose Regimens of Gabapentin for Treating Erythema/Flushing in Rosacea: A Randomized Controlled Trial

> **NCT06776445** · PHASE1 · COMPLETED · sponsor: **First Affiliated Hospital of Chongqing Medical University** · enrollment: 50 (actual)

## Conditions studied

- Rosacea
- Rosacea Subtype 1 (Erythematotelangiectatic)

## Interventions

- **DRUG:** minocycline combined with hydroxychloroquine
- **DRUG:** gabapentin 300mg bid
- **DRUG:** gabapentin 300mg tid

## Key facts

- **NCT ID:** NCT06776445
- **Lead sponsor:** First Affiliated Hospital of Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-05
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-07-31
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06776445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06776445, "Efficacy and Safety of Different Dose Regimens of Gabapentin for Treating Erythema/Flushing in Rosacea: A Randomized Controlled Trial". Retrieved via AI Analytics 2026-07-21 from https://api.ai-analytics.org/clinical/NCT06776445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*